Lexpos News

The Department of Health and Social Care (DHSC) has confirmed that sufficient stock of Clarithromycin 250mg/5ml oral suspension are now available to meet normal demand. As a result the Serious Shortage Protocol (SSP), SSP054 Clarithromycin 250mg/5ml oral suspension at 23.59pm on Friday 17 November 2023. After this date, any prescriptions for Clarithromycin 250mg/5ml oral suspension must be [...]

The post Expiry of SSP054 Clarithromycin 250mg/5ml oral suspension appeared first on Community Pharmacy England.

As a global and local priority, affecting individual patients through to consequences at a population level, antimicrobial resistance (AMR)  and the importance of good antimicrobial stewardship (AMS) has long been a critically important matter for community pharmacists and their teams. Over the last three years that has also been reflected in the content of the [...]

The post Focus on antimicrobial stewardship: PQS appeared first on Community Pharmacy England.

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Rasagiline 1mg tablets. MSN/2023/107 Tier 3 – high impact Date of issue 16th November 2023 Rasagiline 1mg tablets are in limited supply until mid-December 2023. Unlicensed supplies of rasagiline 1mg tablets may be sourced, lead times vary. Selegiline (Eldepryl®) 5mg and [...]

The post Medicine Supply Notification: Rasagiline 1mg tablets appeared first on Community Pharmacy England.

Over the last few years, the community pharmacy sector has demonstrated its commitment to tackling the issue of antimicrobial resistance and worked hard on its involvement in antimicrobial stewardship (AMS) activities. This has included activities in the Pharmacy Quality Scheme over several years. The case study below, from Community Pharmacy Avon,  involves an analysis of [...]

The post Case study: Demonstrating antimicrobial stewardship in community pharmacy appeared first on Community Pharmacy England.